Global Gene EditingMarket
The global gene editing market is estimated to be worth over USD20.23Bnin 2033 and is expected to grow at CAGR of 15.0% during the forecast period (2024-2033).
The global gene editing market is witnessingswift growth, fuelled by technological developments, growing demand for personalized medicine, and substantial investments in research and development. Significant driving factors comprise the surge in genetic disorders and chronic ailments, which has encouraged the need for advanced treatments and therapies. Gene editing technologies such as TALENs, CRISPR-Cas9, and zinc finger nucleases (ZFNs) have transformed the field by providing efficient, precise, and cost-effective techniques for modifying genetic material. This has opened up new possibilities for managing a scale of diseases, from cancer to genetic disorders, and has propelled the development of gene therapies.
Leading opportunities in the market arise from the expanding pipeline of gene therapies, which is accelerating demand for advanced gene editing tools. Pharmaceutical and biotech companies are essentially collaborating with gene editing firms to improve their therapeutic portfolios, fuelling further innovation. The incorporation of artificial intelligence (AI) and machine learning (ML) into gene editing processes is another major development, enhancing the efficiency and accuracy of genetic modifications and minimizing the time and cost of developing new therapies.
Novel applications of gene editing are also emerging beyond human health, significantly in agriculture and industrial biotechnology. In agriculture, gene editing is being used to create crops with higher yields, nutritional content, and resistance to diseases and environmental stresses. In industrial biotechnology, it is applied to engineer microorganisms for the production of biofuels, bioplastics, and other sustainable materials. These applications widens the market scope and appeal diverse investments.
Regardless of its potential, the market witnesses challenges such as ethical and regulatory concerns and technical boundaries like off-target effects. However, continuous research, favorable regulatory developments, and rising acceptance of gene editing technologies are anticipated to diminish these challenges, ensuring sustained market growth. All in all, the global gene editing market stands ready for considerable expansion, spurred by technological advancements and an expanding array of applications.
The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different geographies. Amongst other elements, the market report includes:
A preface providing an introduction to the full report, Gene Editing market, 2023-2033.
An outline of the systematic research methodology adopted to conduct the study on Gene Editing market, providing insights on the various assumptions, methodologies, and quality control measures employed to ensure accuracy and reliability of our findings.
An overview of economic factors that impact the overall Gene Editing market, including historical trends, currency fluctuation, foreign exchange impact, recession, and inflation measurement.
An executive summary of the insights captured during our research, offering a high-level view of the current state of the Gene Editing market and its likely evolution in the mid-to-long term.
A brief introduction to the Gene Editing, highlighting their historical background, as well as information on their types, key aspects, key challenges and the advantages of using Gene Editing.
A detailed assessment of the market landscape of Gene Editing that are either approved or being evaluated in different stages of development, based on several relevant parameters, such as By Product & Services (Reagents & Consumables, Software & Systems, Services), By Technology (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nuclease (TALEN), Zinc Finger Nuclease (ZFN), Antisense, Other Technologies), By Application (Cell Line Engineering, Genetic Engineering, Drug Discovery & Development, Other Applications), By End-user (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Other End Users). Further, the chapter features analysis on key niche market segments. In addition, the chapter features analysis of various Gene Editing developers, based on their year of establishment, company size, location of headquarters and most active players.
An in-depth analysis of partnerships and collaborations that have been inked between various stakeholders, since 2019, based on several relevant parameters, such as the year of partnership, type of partnership, focus of partnership, purpose of partnership, therapeutic applications and most active players (in terms of number of partnerships). It also highlights the regional distribution of partnership activity in this market.
A detailed analysis of various investments made by companies engaged in this industry, since 2019, based on several relevant parameters, such as year of funding, type of funding (grants, seed, venture capital, initial public offering, secondary offerings, private equity and debt financing), type of HPAPIs, amount invested, geography, purpose of funding, stage of development, therapeutic area, most active players (in terms of number and amount of funding instances) and leading investors (in terms of number of funding instances).
An in-depth analysis of the various Gene Editing focused initiatives undertaken by big market players, based on several relevant parameters, such as number of initiatives, year of initiative, type of initiative, purpose of initiative, focus of initiative and location of headquarters of the big pharma players.
One of the key objectives of this market report was to estimate the current market size and the future growth potential of the Gene Editing over the forecast period. Based on several parameters, such as regional analysis as well as segmental analysis rates, we have developed informed estimates of the likely evolution of the Gene Editing market over the forecast period 2023-2033. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as By Product & Services (Reagents & Consumables, Software & Systems, Services), By Technology (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nuclease (TALEN), Zinc Finger Nuclease (ZFN), Antisense, Other Technologies), By Application (Cell Line Engineering, Genetic Engineering, Drug Discovery & Development, Other Applications), By End-user (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Other End Users), by key geographical regions (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) and leading players. In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s evolution.